Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADiTx Therapeutics

10.90
+3.4045.33%
Volume:29.18M
Turnover:284.35M
Market Cap:3.44M
PE:0.00
High:11.85
Open:9.63
Low:8.06
Close:7.50
Loading ...

Aditxt Subsidiary Adimune to Ship Drug Substances for Final Drug Product Formulation of ADI-100 Ahead of Planned Clinical Trials in Type 1 Diabetes and Psoriasis in Germany, and Stiff Person Syndrome at the Mayo Clinic in the U.S.

Business Wire
·
06 Mar

Aditxt subsidiary Persanta engages Dominary Securities for IPO

TipRanks
·
22 Feb

BRIEF-Aditxt Co's Unit Pearsanta Engaged Dominari Securities Llc As Lead Underwriter For Pearsanta's Planned IPO

Reuters
·
21 Feb

Aditxt: Co's Unit Pearsanta Engaged Dominari Securities Llc as Lead Underwriter for Pearsanta's Planned IPO

THOMSON REUTERS
·
21 Feb

Aditxt Subsidiary Pearsanta Engages Dominari Securities for its Initial Public Offering, to Drive U.S. and Global Commercial Launch of Early Cancer Detection and Diagnosis Targeted for H2 2025

Business Wire
·
21 Feb

Aditxt to Host Fireside Chat on Friday, February 21st at 11:30 AM Eastern Time

Business Wire
·
13 Feb

BRIEF-Aditxt’S Board Of Directors Unanimously Approve Positioning Pearsanta For IPO To Support Global Launch Of Its Early Cancer Detection Platform

Reuters
·
13 Jan

Aditxt’s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of Its Early Cancer Detection Platform

THOMSON REUTERS
·
13 Jan

Aditxt Inc - to Explore Pearsanta IPO in 2025

THOMSON REUTERS
·
13 Jan

Aditxt’s Board of Directors Unanimously Approve Positioning Pearsanta for IPO to Support Global Launch of its Early Cancer Detection Platform

Business Wire
·
13 Jan

Aditxt's Subsidiary Adimune Successfully Completes Preclinical Efficacy and Safety Studies for Its Immune Modulation Therapeutic Adi Platform, Advancing Toward First-in-Human Clinical Trials

THOMSON REUTERS
·
12 Dec 2024

BRIEF-Appili Therapeutics Announces Receipt Of Final Court Order For Arrangement With Aditxt, Inc.

Reuters
·
19 Nov 2024

Appili Therapeutics Inc - Court Approves Appili-Aditxt Transaction, Subject to Closing Conditions

THOMSON REUTERS
·
19 Nov 2024

Appili Therapeutics Announces Receipt of Final Court Order for Arrangement with Aditxt, Inc.

GlobeNewswire
·
19 Nov 2024

Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025

THOMSON REUTERS
·
14 Nov 2024

Appili Therapeutics Reports Financial and Operational Results for Second Quarter of Fiscal Year 2025

GlobeNewswire
·
14 Nov 2024